m-AMSA: a review of clinical data

This publication has 9 references indexed in Scilit:

• Quantitative and qualitative effects of m-AMSA (Amsacrine) on cellular immune components
  European Journal of Cancer and Clinical Oncology, 1984
• High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
  Journal of Clinical Oncology, 1984
• Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
  Blood, 1984
• 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia
  American Journal of Clinical Oncology, 1983
• Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults
  Blood, 1982
• A phase I and II study of m-AMSA in acute leukaemia
  Cancer Chemotherapy and Pharmacology, 1981
• Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders
  Blood, 1981
• 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute Leukemia
  Annals of Internal Medicine, 1980
• An assessment of the immunosuppressive activity of the anti-tumour compound 4′-[(9-acridinyl)amino]methanesulphon-m-anisidide (m-AMSA)
  Published by Elsevier ,1974